• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞应激恢复后恢复p53激活,以继续细胞周期进程。

Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression.

作者信息

Lazo Pedro A

机构信息

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain.

出版信息

Cell Signal. 2017 May;33:49-58. doi: 10.1016/j.cellsig.2017.02.005. Epub 2017 Feb 9.

DOI:10.1016/j.cellsig.2017.02.005
PMID:28189587
Abstract

The activation of p53 in response to different types of cellular stress induces several protective reactions including cell cycle arrest, senescence or cell death. These protective effects are a consequence of the activation of p53 by specific phosphorylation performed by several kinases. The reversion of the cell cycle arrest, induced by p53, is a consequence of the phosphorylated and activated p53, which triggers its own downregulation and that of its positive regulators. The different down-regulatory processes have a sequential and temporal order of events. The mechanisms implicated in p53 down-regulation include phosphatases, deacetylases, and protein degradation by the proteasome or autophagy, which also affect different p53 protein targets and functions. The necessary first step is the dephosphorylation of p53 to make it available for interaction with mdm2 ubiquitin-ligase, which requires the activation of phosphatases targeting both p53 and p53-activating kinases. In addition, deacetylation of p53 is required to make lysine residues accessible to ubiquitin ligases. The combined action of these downregulatory mechanisms brings p53 protein back to its basal levels, and cell cycle progression can resume if cells have overcome the stress or damage situation. The specific targeting of these down-regulatory mechanisms can be exploited for therapeutic purposes in cancers harbouring wild-type p53.

摘要

p53响应不同类型的细胞应激而激活,会诱导多种保护反应,包括细胞周期停滞、衰老或细胞死亡。这些保护作用是几种激酶进行的特异性磷酸化激活p53的结果。p53诱导的细胞周期停滞的逆转,是磷酸化并激活的p53的结果,它会触发自身及其正向调节因子的下调。不同的下调过程具有事件的顺序和时间顺序。参与p53下调的机制包括磷酸酶、去乙酰化酶,以及蛋白酶体或自噬介导的蛋白质降解,这些也会影响不同的p53蛋白靶点和功能。必要的第一步是p53的去磷酸化,使其能够与mdm2泛素连接酶相互作用,这需要激活靶向p53和p53激活激酶的磷酸酶。此外,p53的去乙酰化是使赖氨酸残基能够被泛素连接酶识别所必需的。这些下调机制的联合作用使p53蛋白回到其基础水平,如果细胞克服了应激或损伤情况,细胞周期进程就可以恢复。在携带野生型p53的癌症中,这些下调机制的特异性靶向可用于治疗目的。

相似文献

1
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression.细胞应激恢复后恢复p53激活,以继续细胞周期进程。
Cell Signal. 2017 May;33:49-58. doi: 10.1016/j.cellsig.2017.02.005. Epub 2017 Feb 9.
2
Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.抑制中心体蛋白 TACC3 通过激活 p38-p53-p21 应激信号通路诱导 G1 期阻滞和细胞死亡。
Eur J Cell Biol. 2015 Feb;94(2):90-100. doi: 10.1016/j.ejcb.2014.12.001. Epub 2015 Jan 5.
3
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.Wip1磷酸酶在p53-Mdm2自动调节环路中起把关作用。
Cancer Cell. 2007 Oct;12(4):342-54. doi: 10.1016/j.ccr.2007.08.033.
4
The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?多位点磷酸化调控 MDM2——基于分子的肿瘤靶向干预机会?
Semin Cancer Biol. 2010 Feb;20(1):19-28. doi: 10.1016/j.semcancer.2009.10.005. Epub 2009 Nov 6.
5
Mechanisms of p53 degradation.p53降解的机制。
Clin Chim Acta. 2015 Jan 1;438:139-47. doi: 10.1016/j.cca.2014.08.015. Epub 2014 Aug 27.
6
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.Cdk5诱导的p53稳定和激活导致神经元细胞死亡。
J Cell Sci. 2007 Jul 1;120(Pt 13):2259-71. doi: 10.1242/jcs.03468.
7
Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells.药理激活 p53 可阻止细胞周期进程,但不能诱导上皮癌细胞衰老。
Mol Cancer Res. 2009 Sep;7(9):1497-509. doi: 10.1158/1541-7786.MCR-09-0144. Epub 2009 Sep 8.
8
SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.SMAR1与p53-MDM2形成三元复合物,并负向调节p53介导的转录。
J Mol Biol. 2009 May 15;388(4):691-702. doi: 10.1016/j.jmb.2009.03.033. Epub 2009 Mar 19.
9
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.p19(ARF)与Mdm2的结合抑制了Mdm2对肿瘤抑制因子p53的泛素连接酶活性。
EMBO J. 1999 Jan 4;18(1):22-7. doi: 10.1093/emboj/18.1.22.
10
The complexity of p53 stabilization and activation.p53蛋白稳定与激活的复杂性。
Cell Death Differ. 2006 Jun;13(6):941-50. doi: 10.1038/sj.cdd.4401925.

引用本文的文献

1
Protective effects and mechanisms of Saikosaponin A against myocardial ischemia based on network pharmacology, molecular docking, and experimental validation.基于网络药理学、分子对接和实验验证的柴胡皂苷A对心肌缺血的保护作用及机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 14. doi: 10.1007/s00210-025-04203-x.
2
Pharmacological and therapeutic effects of natural products on liver regeneration-a comprehensive research.天然产物对肝脏再生的药理及治疗作用——一项综合研究
Chin Med. 2025 May 6;20(1):57. doi: 10.1186/s13020-025-01108-y.
3
Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression.
XRCC4 缺陷细胞中 BER 和 NHEJ 之间的串扰依赖于端粒酶逆转录酶过表达。
Int J Mol Sci. 2024 Sep 27;25(19):10405. doi: 10.3390/ijms251910405.
4
Nuclear functions regulated by the VRK1 kinase.VRK1 激酶调节的核功能。
Nucleus. 2024 Dec;15(1):2353249. doi: 10.1080/19491034.2024.2353249. Epub 2024 May 16.
5
mycelia cultured in MEB medium produce metabolites with anticancer property.在MEB培养基中培养的菌丝体产生具有抗癌特性的代谢产物。
J Cancer. 2024 Jan 1;15(2):309-316. doi: 10.7150/jca.89059. eCollection 2024.
6
Variation in pentose phosphate pathway-associated metabolism dictates cytotoxicity outcomes determined by tetrazolium reduction assays.戊糖磷酸途径相关代谢的变化决定了噻唑蓝还原检测所确定的细胞毒性结果。
Sci Rep. 2023 May 22;13(1):8220. doi: 10.1038/s41598-023-35310-5.
7
Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs.无功能垂体腺瘤中 MDM2 的表达及临床意义。
Medicina (Kaunas). 2023 Feb 15;59(2):373. doi: 10.3390/medicina59020373.
8
Comprehensive analysis of differentially expressed profiles of mRNA, lncRNA, and miRNA of Yili geese ovary at different egg-laying stages.对不同产蛋期伊犁鹅卵巢中 mRNA、lncRNA 和 miRNA 的差异表达谱进行综合分析。
BMC Genomics. 2022 Aug 19;23(1):607. doi: 10.1186/s12864-022-08774-4.
9
A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.生物无机化学在癌症中突变型 p53 复活中的作用。
J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30.
10
Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.血清来源的外泌体 microRNA-15a 通过 GATA 结合蛋白 2/鼠双微体 2 轴和 p53 信号通路在骨肉瘤细胞中发挥抑瘤作用。
Bioengineered. 2021 Dec;12(1):8378-8395. doi: 10.1080/21655979.2021.1987092.